Ranpirnase

DRUG3 trials

Sponsors

Alfacell, Tamir Biotechnology, Inc.

Conditions

Condylomata AcuminataMalignant MesotheliomaNon-Small Cell Lung CancerPapillomavirus InfectionsSexually Transmitted Diseases

Phase 1

Safety and Efficacy Study of Topical Ranpirnase to Treat Genital Warts (HPV)

CompletedNCT02535104

Tamir Biotechnology, Inc.Condylomata Acuminata, Papillomavirus Infections, Sexually Transmitted Diseases

Start: 2016-02-29End: 2016-09-30Updated: 2018-06-06

Phase 2

A Study Of Ranpirnase(Onconase®) To Pemetrexed Plus Carboplatin In Patients With Non-Squamous Non-Small Cell Lung Cancer

WithdrawnNCT01184287

Tamir Biotechnology, Inc.Non-Small Cell Lung Cancer

Updated: 2015-09-02

Phase 3

ONCONASE Plus Doxorubicin Versus Doxorubicin Alone For Patients With Malignant Pleural or Peritoneal Mesothelioma Who Have Had No More Than One Prior Chemotherapy Regimen

AlfacellMalignant Mesothelioma

Start: 1997-05-31Target: 300Updated: 2013-11-06